We tested the hypothesis that the PPAR-γ activator rosiglitazone improves vascular structure and function in aged hyperhomocysteinemic methylene tetrahydrofolate reductase gene (MTHFR) heterozygous knockout mice (mthfr+/-) fed a high cholesterol diet (HCD), a model of high cardiovascular risk. One year-old mthfr+/- were fed or not HCD (6 mg/Kg/day) and treated or not with rosiglitazone (20 mg/Kg/day) for 90 days, and compared to wild-type mice. Endothelium dependent relaxation of carotid arteries was significantly impaired (-40%) only in rosiglitazone treated HCD-fed mthfr+/-. Carotid media-to-lumen ratio (M/L) and cross-sectional area (CSA) were increased (2-fold) in mthfr+/- fed or not HCD compared to wild-type mice (P<0.05). Rosiglitazone reduced M/L and CSA only in mthfr+/- fed a normal diet. Superoxide production was increased in mthfr+/- fed HCD treated or not with rosiglitazone, whereas plasma nitrite was reduced by rosiglitazone in mice fed or not HCD. Protein arginine methyltransferase-1 (PRMT-1), involved in synthesis of the NO synthase inhibitor asymmetric dimethylarginine (ADMA), and ADMA were increased only in rosiglitazone-treated HCD-fed mthfr+/-. Rosiglitazone had both beneficial and deleterious vascular effects in this animal model of high cardiovascular risk: it prevented carotid remodeling, but impaired endothelial function in part through enhanced oxidative stress and increased ADMA production in mice at high cardiovascular risk.

View original post here:
Countervailing vascular effects of rosiglitazone in high cardiovascular risk mice: Role of oxidative stress and PRMT-1
jouer au poker gratuitement
Tags: hcd, hypothesis, treated-or-not, were-increased
Related posts:
- Obesity is the major contributor to vascular dysfunction and inflammation in high fat diet hypertensive rats
- Tetrahydrobiopterin supplementation reduces atherosclerosis and vascular inflammation in Apolipoprotein E-knockout mice
- Regulation of subcutaneous adipose tissue blood flow is related to measures of vascular and autonomic function
- Rosiglitazone attenuates development of polycystic kidney disease and prolongs the survival in Han: SPRD rats
- High fat diet increases inflammation in the mouse colon
Related posts brought to you by Yet Another Related Posts Plugin.